Finally, autoimmunity has been described in patients with mutations in other genes implicated in B cell activation and proliferation, including PLCγ2, which is responsible for the PLCγ2-associated antibody deficiency and immune dysregulation (PLAID) [25,26]. This evidence concerns the gene PLCG2 and agammaglobulinemia.